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Abstract: Microfabricated devices have been introduced as a promising approach to overcome
some of the challenges related to oral administration of drugs and, thereby, improve their oral
bioavailability. In this study, we fabricate biodegradable microcontainers with different polymers,
namely poly-E-caprolactone (PCL), poly(lactic-co-glycolic acid) (PLGA) 50:50 and PLGA 75:25 by hot
punching. The mucoadhesion of the microcontainers is assessed with an ex vivo retention model on
porcine intestinal tissue. Finally, in vitro degradation studies of the biodegradable microcontainers
are completed for six weeks in simulated intestinal medium with the addition of pancreatic enzymes.
Through SEM inspection, the PLGA 50:50 microcontainers show the first signs of degradation already
after two weeks and complete degradation within four weeks, while the other polymers slowly
degrade in the medium over several weeks.
Keywords: hot punching; embossing; drug delivery; biodegradable polymers; thin films;
microdevices; mucoadhesion; biodegradation
1. Introduction
Oral drug delivery is the most preferred administration route due to its minimally invasive
nature and high patient compliance. Moreover, it provides flexibility to accommodate various types
of drug candidates, as oral dosage forms do not require sterile manufacturing conditions and are
therefore less expensive to manufacture. However, oral drug delivery faces several challenges, such as
pre-systemic intestinal degradation, hepatic first pass elimination, as well as low solubility of some
drugs in the fluids of the gastrointestinal (GI) tract, leading to reduced oral bioavailability of the
drug [1,2]. One goal in the development of oral drug delivery systems is to reduce the dosage and
thereby minimize the adverse effects of the drug, which can be achieved by increasing the amount
of drug specifically released and absorbed at the targeted site in the GI tract. In the last decades,
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mucoadhesion has been shown increased interest in oral drug delivery as it potentially enhances
the bioavailability due to longer retention times of drug at the intended sites of absorption [3,4].
In particular, mucoadhesive drug delivery systems could be of value in delivering the growing number
of sensitive high molecular-weight compounds, such as peptides and proteins [5]. Numerous methods
have been proposed to assess the mucoadhesive properties of drug formulations in vitro and ex vivo.
These methods can be based on mechanical force determination or on particle interactions [6].
Recently, microfabricated drug delivery systems have been proposed to overcome some of the
major challenges in oral drug delivery [7]. For this purpose, microcontainer devices with precisely
controlled dimensions and shapes have been introduced [8,9]. Microcontainers are reservoir-based
devices, providing a large surface area. After the fabrication of microcontainers, active pharmaceutical
ingredients (APIs) in various forms can be loaded into the cavities. This is convenient and avoids
potential harm to the drug during the microcontainer processing steps. To control the release kinetics,
functional coatings can then be applied on the loaded microcontainers. Due to the design of the devices,
they can potentially provide unidirectional release at the intestinal mucosa, control of drug release
kinetics, and facilitate targeted delivery of pharmaceuticals in the GI tract [10–12].
Based on the demand of fabricating microdevices in biocompatible and biodegradable materials,
we recently demonstrated the successful fabrication of biodegradable microcontainers using hot
punching, which is a modified hot embossing method [12]. The novel process is based on the assembly
of compression molded polymer films, after which a single processing step produces simultaneous
patterning of the device film and thermal bonding to an underlying water soluble poly(vinyl alcohol)
(PVA) substrate. This results in replication of large arrays of microcontainers on a sacrificial film, which
afterwards can be dissolved in an aqueous solution for harvesting of the devices. Thus far, this method
has been applied for the fabrication of microcontainers with poly-ε-caprolactone (PCL).
Recently, an ex vivo method was presented for characterization of the mucoadhesive properties
of microcontainers and other microfabricated devices intended for oral drug delivery [13]. It is a
simple, yet efficient method, where a capsule containing the devices is placed at the top end of an
untreated and inclined piece of porcine small intestine. The tissue is perfused with a simulated
intestinal medium followed by microscope examination. Using this method, a study was completed
evaluating mucoadhesion of the PCL microcontainers fabricated by hot punching. The results showed
good adhesion to the intestine with over 60% of the devices residing in the first few cm of intestine [13].
While this is promising for sustained drug delivery, it raises the concern that the microcontainers might
accumulate in the GI tract upon repeated administrations. This illustrates that the degradation of the
polymeric materials used for oral drug delivery applications is another critical factor to consider. PCL
is a polyester with a relatively low degradation rate in physiological conditions [14,15]. By adjusting
the fabrication process of biodegradable microcontainers, it could be possible to change the material to
a biodegradable polymer with faster degradation and similar, or even better, mucoadhesive properties.
A polymer that has attracted considerable interest as a base material in biomedical applications, due to
its biocompatibility and tailorable biodegradation rate, is poly(lactic-co-glycolic acid) (PLGA) [16–18].
It is a co-polymer approved by the U.S. Food and Drug Administration (FDA) for several medical
applications, such as drug delivery and tissue engineering, due to its non-toxicity in humans [16,18].
In the presence of an aqueous environment, PLGA undergoes hydrolytic degradation to produce lactic
and glycolic acid, which are products of normal metabolic pathways in the human body. Based on the
percentage of glycolic acid and lactic acid in PLGA, the physical properties, such as the hydration and
hydrolysis rate, are different [18].
The aim of this work is to evaluate the suitability of different polymeric materials for microfabricated
drug delivery devices where mucoadhesive properties and biodegradability are important. For this
purpose, we fabricate microcontainers in PLGA 50:50, PLGA 75:25, and PCL with the hot punching
process. Furthermore, we assess and compare the biodegradation in vitro and investigate the
mucoadhesion of these microcontainers ex vivo. The degradation studies are completed in a simulated
intestinal medium to evaluate the structural integrity of the microcontainers upon prolonged exposure.
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2. Materials and Methods
2.1. Microcontainer Fabrication
PVA (Mowiflex C17) was provided by Kuraray (Vantaa Finland) and PCL (Mn = 80,000 g mol−1)
was purchased from Sigma Aldrich (Schnelldorf, Germany) . Circular polymer films with a diameter
of approximately 100 mm were prepared by compression molding with a hot embosser (Collin®Press,
300 SV, Ebersberg, Germany) as described earlier [12].
A series of optimization steps were carried out in order to achieve uniform PLGA 50:50 (acid end
cap, Mn 85,000–100,000 g/mol, Akina, IN, US) and PLGA 75:25 (acid end cap, Mn 75,000–85,000 g/mol,
Akina, IN, US) films with thicknesses corresponding to the height of the desired microcontainer
structures. For PLGA 50:50, compression molding temperature was varied between 70 and 90 ◦C and a
film thickness of 83 ± 7 µm was achieved with the optimized parameters, as shown in Table 1. For
PLGA 75:25, similar experiments were conducted where the temperature was varied between 90 and
110 ◦C, while the pressure and holding time were kept the same as for PLGA 50:50. The process was
stopped at room temperature and a thickness of 86 ± 10 µm was achieved at a temperature of 105 ◦C.
Table 1. Parameters for compression molding of poly(lactic-co-glycolic acid) (PLGA) 50:50 and
75:25 films.
Material Amount [mg] CompressionTime [min]
Holding
Temperature [◦C]
Cooling Ramp
[K/min]
Platen
Pressure [bar]
PLGA 50:50 250 ± 20 30 90 20 20
PLGA 75:25 400 ± 200 30 105 20 20
Nickel stamps with the microcontainer patterns were fabricated using dry etching and
electroplating in a similar manner as described by Petersen et al. [19]. PLGA 50:50 and PLGA
75:25 microcontainers were fabricated using a similar process flow as for PCL microcontainers
presented earlier [12]. A simple assembly of the compression molded polymer films was performed
prior to a single step of simultaneous thermal bonding and patterning based on hot punching, as shown
in Figure 1. A 28 × 28 mm2 PVA substrate was used as the sacrificial substrate and the PLGA device
film with the same dimensions was assembled on top of it. Due to the high adhesion forces between
PLGA and the Ni stamp, a polytetrafluoroethylene (PTFE) film (thickness 0.01 mm, Sigma Aldrich,
Schnelldorf, Germany) was added. It was also cut in 28 × 28 mm2 to fit 4 × 400 microcontainers. The
PLGA device film was molded and punched by the Ni stamp (80◦C, 600 s, and platen pressure at
12 bars). After the punching process was finished, the temperature was decreased to 50◦C with a
cooling ramp of 20 ◦C min−1. Then, the stamp and the un-punched PTFE film were demolded from
the polymer by mechanical peeling of the surrounding film, as shown in Figure 1D.
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Figure 1. Schematic illustration of: (a) the assembly of poly(vinyl alcohol) (PVA) substrate film, a
biodegradable PLGA device film, and a polytetrafluoroethylene (PTFE) film prior to the fabrication
process; (b) hot punching is performed by applying pressure and heat; (c) a demolding step of the
Ni stamp is completed, leading to separation of PLGA microcontainers from the surrounding film;
(d) mechanical peeling of the surrounding PLGA film.
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Optical profiler measurements were performed with a PLu neox 3D optical profilometer (Sensofar,
Barcelona, Spain). Vertical scanning interferometry (VSI) measurements (20×) were conducted on
five locations on the samples by attaching it to a silicon carrier wafer using Kapton tape in order to
ensure a relatively planar surface prior to optical profiler measurements. Stylus profiler (Dektak XTA,
Bruker, Karlsruhe, Germany) measurements were performed to ensure correct height determination by
VSI. The data was analyzed using the free SPM data analysis software Gwyddion (version 2.52), and
the data was levelled with respect to the indentations. Heights were determined based on profiles
extracted across the center of the microcontainers. VSI scans were performed near the center and in
each of the four corners of the samples. More detailed scans were also made for use in 3D rendering.
2.2. Harvesting of Biodegradable Microcontainers
For harvesting of the PCL and PLGA microcontainers, the PVA substrate was dissolved. The
dissolution of the sacrificial PVA was achieved by immersion in aqueous medium [12]. A sample
containing 400 microcontainers was dissolved within 30 min. Subsequently, the free-floating
microcontainers were harvested using a stainless steel filter with a mesh opening of 213 µm and
thickness of 178 µm (Spectra/Mesh®Woven Filters, Fisher Scientific, Roskilde, Denmark). The
microcontainers were dried at 37 ◦C for 1 h. For further investigation, the filter containing the harvested
microcontainers was mounted on aluminum stubs with double-sided carbon adhesive dots. Scanning
electron microscopy (SEM) was performed to study the surface and morphology of the microcontainers.
All SEM micrographs were acquired by a TM3030Plus Tabletop Microscope (Hitachi, Krefeld, Germany)
with a voltage of 15 keV using the SE detector.
2.3. Ex Vivo Mucoadhesion Studies with Biodegradable Microcontainers
The ex vivo mucoadhesion studies were conducted as described by Mosgaard et al. [13] and
conducted under the license number DK-10-13-oth-736416. An 18 cm piece of small intact intestinal
porcine tissue was placed on an angled tissue holder at 20◦ inside a humidity and heat controlled
chamber. The intestine was flushed with fasted state simulated intestinal fluid (FaSSIF, pH 6.5, 37 ◦C,
Biorelevant®, London, UK) for 15 min with a flow rate of 4.1 mL/min using a peristaltic pump. Then,
the angle was set to 10◦ and the tissue was flushed for 5 min at a flow rate of 1.55 mL/min. Gelatin
capsules loaded with a known amount of microcontainers were placed at the top of the intestine and
were allowed to dissolve for 15 min. The tissue holder was placed back at an angle of 20◦ and the
intestine was perfused for 30 min at a flow rate of 1.55 mL/min. This flow rate was calculated based on
earlier studies by Sinko et. al, reporting flow rates for rats of 0.2 mL/min and assuming a size ratio of
7.5 between a pig and rat intestine [20–22]. At the end of the study, the tissue was cut open and divided
into 3 sections named “start”, “middle”, and “end”; each having a length of approximately 6 cm.
The microcontainers found on the filter paper were referred to as “exit”. The tissue was transferred
onto microscope slides and dried overnight at room temperature before visualization under a light
microscope. The amount of microcontainers on each intestinal piece and the amount of microcontainers
exiting the tissue were assessed.
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2.4. Degradation Study in Intestinal Medium
Degradation studies were performed in FaSSIF medium with added pancreatin enzymes, as
they play a vital role in protein digestion in the small intestine and are the main enzymes used when
simulating digestion [23]. Pancreatin from porcine pancreas (≥3 × USP specifications, Sigma Aldrich,
St. Louis, MO, USA, 11.92 USPU/mg activity) was added to yield a lipase activity of 600 USPU/mL.
The pancreatic extract was prepared by adding pancreatin to FaSSIF and vortexing until homogeneity
was achieved. Afterwards, the mixture was centrifuged for 7 min at 4000 rpm and the supernatant was
collected. The pH was adjusted to 6.5. The microcontainers were placed in 3 mL FaSSIF–pancreatin
medium and the vials were kept in a 37◦C waterbath with constant stirring (100 rpm). The medium
was changed three times a week by filtering the microcontainers from the old medium. Once per week,
the microcontainers were dried and investigated by SEM. The investigated samples were placed back
in the vial before adding freshly prepared medium, and this was continued until no microcontainers
could be found in the medium.
3. Results and Discussion
3.1. Fabrication of PLGA Microcontainers
First, the fabrication of PLGA microcontainers by hot punching had to be optimized. The PLGA
film was molded and finally punched due to shear stress at the highest protrusion of the stamp,
which exceeded the ultimate tensile strength of the material, as shown in Figure 2a. By the addition
of the PTFE film between the stamp and the PLGA device film, it was possible to avoid adhesion
between the stamp and the PLGA device film upon demolding. After the hot punching process, the
sacrificial PTFE film could easily be peeled off. The microcontainers were physically separated from
the surrounding PLGA and remained on the underlying PVA substrate, as shown in Figure 2b–d.
Microcontainers were successfully fabricated with PLGA 50:50 and 75:25 in arrays of 20 × 20 devices in
a single-step hot punching process. The PVA substrate was dissolved in aqueous medium and the
microcontainers were harvested on a grid, showing good structural definition and integrity, as shown
in Figure 2e. SEM images revealed an excellent replication fidelity. The inner and outer diameter
were 240 ± 2 µm and 275 ± 0.5 µm, respectively, the height was 73 ± 6 µm, and the reservoir depth
was 56 ± 1 µm as investigated through optical profilometry and shown in Figure 2f,g. Compared to
the PCL microcontainers fabricated with the identical Ni stamp [12], it was observed that the PLGA
microcontainers were slightly lower. This was attributed to the PTFE film added during the hot
punching step, which was not required for PCL. The inner diameter was 10 µm larger for PLGA
microcontainers compared to PCL, which was expected as the PFTE had enlarged the stamp features.
This led to different volumes of the PLGA and PCL microcontainers of 1.8 and 3.8 nL, respectively. The
weight of a single microcontainer was determined experimentally by weighing a defined amount of
devices. For PCL, the weight was 3.7 ± 0.4 µg, PLGA 50:50 had a weight of 2.7 ± 0.4 µg, and PLGA
75:25 weighed 3.6 ± 0.04 µg. This was in good agreement with the values estimated based on the
measured dimensions and the polymer density.
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3.2. Ex Vivo Mucoadhesion Study
After harvesting the microcontainers from the PVA substrate, ex vivo mucoadhesion tests on
porcine small intestinal tissue were performed. The ex vivo retention test was used to evaluate the
behavior of the microcontainers in the small intestine when exposed to a constant flow. The observation
of the movement of the microcontainers down the small intestine, as shown in Supplementary Materials
S2, indicates their interaction with the mucus layer. Prolonged movement of the microcontainers
down the small intestine can be related to lower mucoadhesion. The recovery rate, which is the
percentage of microcontainers that could be identified during the experiments, was 82 ± 6% for PLGA
50:50, 69 ± 10% for PLGA 75:25, and 88 ± 4% for PCL. It is assumed that the missing microcontainers
were lost in a distributed manner through all intestinal sections and at the exit. A comparison of the
relative percentages of PLGA 50:50, PLGA 75:25, and PCL microcontainers that could be identified
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in the respective sections is shown in Figure 3. It was observed that most of the microcontainers
(between 66 and 82%) were located in the first part of the intestinal tissue, which indicates their ability
to adhere well to the mucosal surface. The microcontainers were then more or less equally distributed
throughout the rest of the intestinal sections. A slight tendency of PLGA microcontainers adhering
better in the beginning of the tissue was observed compared to PCL microcontainers. A variety of
factors could affect mucoadhesion, including the chemical structure which would lead to different
interactions on the mucosal surface [24]. PLGA has a more hydrophilic structure than PCL, which
can result in numerous hydrogen bonds with the mucus layer. PCL could, on the other hand, present
hydrophobic interactions with mucus which explains the good ability to adhere in the beginning of the
intestine [20,24]. Also, the size of the microcontainers could have an influence on the mucoadhesion.
As the PLGA microcontainers had a slightly smaller diameter, they might have been less affected by
the constant flow after adhering to the mucosal surface.
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Figure 3. Percentage of microcontainers located in the start, middle, end, and exit of the s all
intestine of a pig after an ex vivo perfusion study. Comparison of poly-E-caprolactone (PCL) (black)
microcontainers, PLGA 75:25 (dark grey), and PLGA 50:50 (light grey). Data is presented as mean ± SD
with n = 3–4.
Minor variations between the two PLGA polymers were also observed. PLGA 50:50
microcontainers seemed slightly more prone to adhere to the mucus compared to PLGA 75:25.
PLGA 50:50 has more hydrophilic functional groups, such as hydroxyl and carboxyl, which could again
allow for better hydrogen bonding, thereby promoting maximal exposure of potential anchor sites.
3.3. In Vitro Degradation Study in Int stinal Medium
The morphology of the microcontainers was analyzed by SEM before and during degradation
in FaSSIF with pancreatin, as seen in Figure 4. PLGA 50:50 microcontainers already showed signs of
degradation and loss of structural integrity in the first SEM analysis after two weeks. In comparison,
PLGA 75:25 and PCL microcontainers only had minor deformation of the microcontainer walls in both
cases. After four weeks, PLGA 50:50 microcontainers were completely degraded and thus, could not
be detected anymore via SEM inspection. At the same time, PLGA 75:25 and PCL devices showed
clear signs of degradation by changing structural integrity and even breaking apart. After five weeks,
the morphology of those microcontainers had completely changed and only small polymer lumps
remained. Finally, after six weeks, none of the three polymers could be detected through SEM. The
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observed degradation for all three polymers was faster compared to what would be expected from
typical degradation studies reported in the literature. For PCL in an aqueous environment without
any enzymes, degradation is typically slow, which would not allow complete degradation of the
microcontainers within six weeks [14,15]. This is also supported by the fact that PCL microcontainers
immersed in FaSSIF medium without enzymes were completely unaffected after 20 d, as shown in
Supplementary Materials S1. The porcine pancreatin added in the FaSSIF medium contains a mixture
of enzymes, including lipase, which readily hydrolyzes ester bonds in polyesters [23]. Furthermore,
PCL is generally known to be degraded by microorganisms, as well as by hydrolytic mechanisms,
under physiological conditions [25]. PLGA has been proposed to degrade primarily through hydrolytic
degradation, but it has also been suggested that enzymatic degradation may play a role in the
process [26,27]. Among all the tested polymers, PCL seemed to have the slowest biodegradation
rate and literature also evidences that it is a slower degrading polymer in comparison to PLGA [26].
Regarding the difference between PLGA 50:50 and 75:25, it was expected that the degradation time
would vary as different ratios of the monomers have a significant influence on hydrolysis and enzymatic
degradation. PLGA 50:50 is expected to have the highest degradation rate compared to PLGA 75:25,
which typically is approximately twice as slow due to the higher content of hydrophobic groups [27].
This corresponds well to what was observed during the degradation study. It should be noted, that
in vivo degradation would be expected to occur even faster due to presence of bacteria and other
enzymes in the GI tract.
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4. Conclusions
In this study, mucoadhesion and degradation of polymeric microcontainers for oral drug
delivery were investigated. For this purpose, the hot punching process f r the fab ication of PLGA
microcontain rs had to b optimized. Due to high adhesion forces f PLGA polyme to the Ni stamp,
an additional PTFE film was add between the stamp and th PLGA device film. This eased the
demolding process and thus PLGA microcontainers in two different compositions, namely PLGA 50:50
and 75:25, were successfully fabricated. This demonstra es the v satility of the recently developed
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single-step hot punching method. The fabricated microcontainers were assessed in an ex vivo retention
model for their mucoadhesion properties. It was found that PLGA 50:50 microcontainers showed the
best mucoadhesion characteristics compared to PCL and PLGA 75:25 microcontainers. The degradation
properties of the three types of biodegradable microcontainers were also evaluated in an in vitro
study for six weeks using simulated intestinal medium with the addition of enzymes. Through SEM
inspection, it was found that PLGA 50:50 degraded the fastest and no microcontainers could be detected
already after four weeks. PCL and PLGA 75:25 microcontainers were completely degraded after six
weeks. The results indicate that the fabrication method can indeed be used for various purposes of
oral drug delivery and that PLGA 50:50 has the best mucoadhesion and the fastest biodegradation.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4360/11/11/1828/s1,
Figure S1: Degradation study of PCL microcontainers in PBS, PaSSGF and FaSSIG media for up to 20 days; Figure
S2: Microcontainers inside the porcine intestine visualized with an optical microscope.
Author Contributions: Conceptualization, Z.A., M.D.M., S.S.K.; Methodology, Z.A., M.D.M., L.H.N., S.S.K.;
Validation, Z.A., G.M., M.D.M.; Formal analysis, Z.A., M.D.M., G.M., S.S.K.; Investigation, Z.A., M.D.M., G.M.;
Resources, A.B., S.S.K.; Data curation, Z.A., M.D.M., G.M.; Writing – original draft preparation, Z.A., M.D.M.;
Writing – review and editing, Z.A., M.D.M., R.S.P., L.H.N., A.M., A.B., S.S.K.; Visualization, Z.A., M.D.M.;
Supervision, R.S.P., L.H.N., A.M., A.B., S.S.K.; Project administration, A.B., S.S.K.; Funding acquisition, A.B.
Funding: This research was funded by The Danish National Research Foundation (Project DNRF122) and Villum
Foundation’s Center (Grant No. 9301) for Intelligent Drug Delivery and Sensing Using Microcontainers and
Nanomechanics (IDUN).
Acknowledgments: The foundations are acknowledged for financial support. Fabrication specialist Lasse
Thamdrup is acknowledged for the thorough optical and stylus measurements.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Taylor, L.S.; Zhang, G.G.Z. Physical chemistry of supersaturated solutions and implications for oral absorption.
Adv. Drug Deliv. Rev. 2016, 101, 122–142. [CrossRef]
2. Agrawal, U.; Sharma, R.; Gupta, M.; Vyas, S.P. Is nanotechnology a boon for oral drug delivery?
Drug Discov. Today. 2014, 19, 1530–1546. [CrossRef]
3. Pereira De Sousa, I.; Steiner, C.; Schmutzler, M.; Wilcox, M.D.; Veldhuis, G.J.; Pearson, J.P.; Huck, C.W.;
Salvenmoser, W.; Bernkop-Schnürch, A. Mucus permeating carriers: Formulation and characterization of
highly densely charged nanoparticles. Eur. J. Pharm. Biopharm. 2015, 97, 273–279. [CrossRef]
4. Champion, J.A.; Katare, Y.K.; Mitragotri, S. Particle shape: A new design parameter for micro- and nanoscale
drug delivery carriers. J. Control. Release 2007, 121, 3–9. [CrossRef] [PubMed]
5. Shaikh, R.; Raj Singh, T.R.; Garland, M.J.; Woolfson, A.D.; Donnelly, R.F. Mucoadhesive drug delivery
systems. J. Pharm Bioallied Sci. 2011, 3, 89–100. [PubMed]
6. Mackie, A.R.; Goycoolea, F.M.; Menchicchi, B.; Caramella, C.M.; Saporito, F.; Lee, S.; Stephansen, K.;
Chronakis, I.S.; Hiorth, M.; Adamczak, M.; et al. Innovative Methods and Applications in Mucoadhesion
Research. Macromol. Biosci. 2017, 17, 1–32. [CrossRef] [PubMed]
7. Nielsen, L.H.; Keller, S.S.; Boisen, A. Microfabricated devices for oral drug delivery. Lab Chip 2018,
18, 2348–2358. [CrossRef] [PubMed]
8. Tao, S.L.; Lubeley, M.W.; Desai, T.A. Bioadhesive poly(methyl methacrylate) microdevices for controlled
drug delivery. J. Control. Release 2003, 88, 215–228. [CrossRef]
9. Ainslie, K.M.; Lowe, R.D.; Beaudette, T.T.; Petty, L.; Bachelder, E.M.; Desai, T.A. Microfabricated devices for
enhanced bioadhesive drug delivery: Attachment to and small-molecule release through a cell monolayer
under flow. Small 2009, 5, 2857–2863. [CrossRef] [PubMed]
10. Mazzoni, C.; Tentor, F.; Strindberg, S.A.; Nielsen, L.H.; Keller, S.S.; Alstrøm, T.S.; Gundlach, C.;
Müllertz, A.; Marizza, P.; Boisen, A. From concept to in vivo testing: Microcontainers for oral drug
delivery. J. Control. Release 2017, 268, 343–351. [CrossRef] [PubMed]
11. Nielsen, L.H.; Melero, A.; Keller, S.S.; Jacobsen, J.; Garrigues, T.; Rades, T.; Müllertz, A.; Boisen, A. Polymeric
microcontainers improve oral bioavailability of furosemide. Int. J. Pharm. 2016, 504, 98–109. [CrossRef]
[PubMed]
Polymers 2019, 11, 1828 10 of 10
12. Abid, Z.; Strindberg, S.; Javed, M.M.; Mazzoni, C.; Vaut, L.; Nielsen, L.H.; Gundlach, C.; Petersen, R.S.;
Müllertz, A.; Boisen, A.; et al. Biodegradable microcontainers—Towards real life applications for oral drug
delivery. Lab Chip 2019, 19, 2905–2914. [CrossRef] [PubMed]
13. Mosgaard, D.M.; Strindberg, S.; Abid, Z.; Petersen, R.S.; Thamdrup, L.; Keller, S.S.; Müllertz, A.; Nielsen, L.H.
Ex vivo intestinal perfusion model for investigating mucoadhesion of microcontainers. Int. J. Pharm. 2019,
570, 18658.
14. Heimowska, A.; Morawska, M.; Bocho-janiszewska, A. Biodegradation of poly(ε-caprolactone ) in natural
water environments. Pol. J. Chem. Technol. 2017, 1, 120–126. [CrossRef]
15. Abedalwafa, M.; Wang, F.; Wang, L.; Li, C. Biodegradable poly-epsilon-caprolactone (pcl) for tissue
engineering applications: A review. Rev. Adv. Mater. Sci. 2013, 34, 123–140.
16. Gentile, P.; Chiono, V.; Carmagnola, I.; Hatton, P.V. An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based
Biomaterials for Bone Tissue Engineering. Int. J. Mol. Sci. 2014, 15, 3640–3659. [CrossRef]
17. Ding, D.; Kundukad, B.; Somasundar, A.; Vijayan, S.; Khan, S.A.; Doyle, P.S. Design of Mucoadhesive PLGA
Microparticles for Ocular Drug Delivery. ACS Appl. Bio Mater. 2018, 1, 561–571. [CrossRef]
18. Makadia, H.K.; Siegel, S.J. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery
Carrier. Polymers 2011, 3, 1–19. [CrossRef]
19. Petersen, R.S.; Keller, S.S.; Hansen, O.; Boisen, A. Fabrication of Ni stamp with high aspect ratio, two-leveled,
cylindrical microstructures using dry etching and electroplating. J. Micromech. Microeng. 2015, 25, 055021.
[CrossRef]
20. Sinko, P.J.; Hu, P.; Waclawski, A.P.; Patel, N.R. Oral absorption of anti-aids nucleoside analogues. 1. Intestinal
transport of didanosine in rat and rabbit preparations. J. Pharm. Sci. 1995, 84, 959–965. [CrossRef]
21. Kararli, T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and
commonly used laboratory animals. Biopharm. Drug Dispos. 1995, 16, 351–380. [CrossRef] [PubMed]
22. Sjögren, E.; Abrahamsson, B.; Augustijns, P.; Becker, D.; Bolger, M.B.; Brewster, M.; Brouwers, J.; Flanagan, T.;
Harwood, M.; Heinen, C.; et al. In vivo methods for drug absorption—comparative physiologies, model
selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient
characterization including food effects. Eur. J. Pharm. Sci. 2014, 57, 99–151. [CrossRef] [PubMed]
23. Whitcomb, D.C.; Lowe, M.E. Human pancreatic digestive enzymes. Dig. Dis. Sci. 2007, 52, 1–17. [CrossRef]
24. Sigurdsson, H.H.; Kirch, J.; Lehr, C.-M. Mucus as a barrier to lipophilic drugs. Int. J. Pharm. 2013, 453, 56–64.
[CrossRef] [PubMed]
25. Armani, D.K.; Liu, C. Microfabrication Technology for Polycaprolactone, A Biodegradable Polymer.
J. Micromech. Microeng. 2000, 10, 80. [CrossRef]
26. Schliecker, G.; Schmidt, C.; Fuchs, S.; Wombacher, R.; Kissel, T. Hydrolytic degradation of
poly(lactide-co-glycolide) films: Effect of oligomers on degradation rate and crystallinity. Int. J. Pharm. 2003,
266, 39–49. [CrossRef]
27. Park, T.G. Degradation of poly(d,l-lactic acid) microspheres: Effect of molecular weight. J. Control. Release
1994, 30, 161–173. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
